These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21221844)

  • 1. POLG1-related and other "mitochondrial Parkinsonisms": an overview.
    Orsucci D; Caldarazzo Ienco E; Mancuso M; Siciliano G
    J Mol Neurosci; 2011 May; 44(1):17-24. PubMed ID: 21221844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease.
    Luoma PT; Eerola J; Ahola S; Hakonen AH; Hellström O; Kivistö KT; Tienari PJ; Suomalainen A
    Neurology; 2007 Sep; 69(11):1152-9. PubMed ID: 17846414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle.
    Baloh RH; Salavaggione E; Milbrandt J; Pestronk A
    Arch Neurol; 2007 Jul; 64(7):998-1000. PubMed ID: 17620490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial progressive external opthalmoplegia, parkinsonism and polyneuropathy associated with POLG1 mutation].
    Mukai M; Sugaya K; Matsubara S; Cai H; Yabe I; Sasaki H; Nakano I
    Rinsho Shinkeigaku; 2014; 54(5):417-22. PubMed ID: 24943079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.
    Palin EJ; Paetau A; Suomalainen A
    Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a Y955C mutation in POLG1.
    Mukai M; Sugaya K; Yabe I; Goto Y; Yokochi F; Miyamoto K; Cai H; Sasaki H; Matsubara S
    Parkinsonism Relat Disord; 2013 Sep; 19(9):821-4. PubMed ID: 23673011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype.
    Komulainen T; Hinttala R; Kärppä M; Pajunen L; Finnilä S; Tuominen H; Rantala H; Hassinen I; Majamaa K; Uusimaa J
    BMC Neurol; 2010 May; 10():29. PubMed ID: 20438629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset presentation of POLG1-associated mitochondrial disease.
    Meira B; Roque R; Pinto M; Caetano A
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA
    Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism.
    Invernizzi F; Varanese S; Thomas A; Carrara F; Onofrj M; Zeviani M
    Neuromuscul Disord; 2008 Jun; 18(6):460-4. PubMed ID: 18502641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene.
    Delgado-Alvarado M; de la Riva P; Jiménez-Urbieta H; Gago B; Gabilondo A; Bornstein B; Rodríguez-Oroz MC
    J Neurol Sci; 2015 Mar; 350(1-2):93-7. PubMed ID: 25724872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.
    Horvath R; Hudson G; Ferrari G; Fütterer N; Ahola S; Lamantea E; Prokisch H; Lochmüller H; McFarland R; Ramesh V; Klopstock T; Freisinger P; Salvi F; Mayr JA; Santer R; Tesarova M; Zeman J; Udd B; Taylor RW; Turnbull D; Hanna M; Fialho D; Suomalainen A; Zeviani M; Chinnery PF
    Brain; 2006 Jul; 129(Pt 7):1674-84. PubMed ID: 16621917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variations in 3 children with POLG1 mutations.
    Burusnukul P; de los Reyes EC
    J Child Neurol; 2009 Apr; 24(4):482-6. PubMed ID: 19189930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
    Luoma P; Melberg A; Rinne JO; Kaukonen JA; Nupponen NN; Chalmers RM; Oldfors A; Rautakorpi I; Peltonen L; Majamaa K; Somer H; Suomalainen A
    Lancet; 2004 Sep 4-10; 364(9437):875-82. PubMed ID: 15351195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POLG1-related levodopa-responsive parkinsonism.
    Miguel R; Gago MF; Martins J; Barros P; Vale J; Rosas MJ
    Clin Neurol Neurosurg; 2014 Nov; 126():47-54. PubMed ID: 25203713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations.
    Tang S; Dimberg EL; Milone M; Wong LJ
    J Neurol; 2012 May; 259(5):862-8. PubMed ID: 21993618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions.
    Betts-Henderson J; Jaros E; Krishnan KJ; Perry RH; Reeve AK; Schaefer AM; Taylor RW; Turnbull DM
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):120-4. PubMed ID: 19187065
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic aetiology of ophthalmological manifestations in children - a focus on mitochondrial disease-related symptoms.
    Widgren P; Hurme A; Falck A; Keski-Filppula R; Remes AM; Moilanen J; Majamaa K; Kervinen M; Uusimaa J
    Acta Ophthalmol; 2016 Feb; 94(1):83-91. PubMed ID: 26448634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase gamma 1 mutations: clinical correlations.
    Milone M; Massie R
    Neurologist; 2010 Mar; 16(2):84-91. PubMed ID: 20220442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.
    Ashley N; O'Rourke A; Smith C; Adams S; Gowda V; Zeviani M; Brown GK; Fratter C; Poulton J
    Hum Mol Genet; 2008 Aug; 17(16):2496-506. PubMed ID: 18487244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.